In the majority of NSCLC tumors, hnRNPA1/A2 and IRF-3 were overexpressed, suggesting that hnRNPA1/A2 may play a role in maintaining an immune suppressive microenvironment in NSCLC tumors [244]. The gene discussed is HNRNPA1; the disease is non-small cell lung carcinoma.